{"title":"Bosutinib finds its place in the CML treatment paradigm","authors":"M. Deininger","doi":"10.12788/J.CMONC.0002","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":72649,"journal":{"name":"Community oncology","volume":"10 1","pages":"103-104"},"PeriodicalIF":0.0000,"publicationDate":"2013-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Community oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12788/J.CMONC.0002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}